Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes

Background: Insulin glargine 300 U/mL (Gla-300) has a more constant and prolonged action profile than insulin glargine 100 U/mL and in clinical studies is associated with similar glycemic control but less hypoglycemia. Whether its effects are altered by variability of injection time was examined in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Technol Ther
Main Authors: Riddle, Matthew C., Bolli, Geremia B., Home, Philip D., Bergenstal, Richard M., Ziemen, Monika, Muehlen-Bartmer, Isabel, Wardecki, Marek, Vinet, Laetitia, Jeandidier, Nathalie, Yki-Järvinen, Hannele
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4827283/
https://ncbi.nlm.nih.gov/pubmed/26840338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2015.0290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados